COMMUNIQUÉS West-GlobeNewswire

-
Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
12/06/2024 -
BioSyent In-Licenses Endocrinology Product for Canada
12/06/2024 -
Precipio Provides Status Update on Current Business Matters
12/06/2024 -
Philips launches Duo Venous Stent System for treatment of symptomatic venous outflow obstruction
12/06/2024 -
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
12/06/2024 -
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
12/06/2024 -
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
12/06/2024 -
Streamline Health® Reports Fiscal First Quarter 2024 Financial Results
11/06/2024 -
Voting Rights and Shares Capital of the Company
11/06/2024 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
11/06/2024 -
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance
11/06/2024 -
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
11/06/2024 -
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
11/06/2024 -
Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
11/06/2024 -
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
11/06/2024 -
Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
11/06/2024 -
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
11/06/2024 -
New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets
11/06/2024 -
Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection
11/06/2024
Pages